Inactive Instrument

Company Ibex Technologies




Business Summary

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


Managers TitleAgeSince
Chief Executive Officer - 94-12-31
Director of Finance/CFO - 20-11-05
Chief Operating Officer - 18-09-16

Members of the board

Members of the board TitleAgeSince
Director/Board Member 78 99-12-31
Chief Executive Officer - 94-12-31
Director/Board Member - 21-06-15
Director/Board Member - 06-12-31
Director/Board Member 55 17-10-10
Director/Board Member - 17-10-10

Company contact information

IBEX Technologies, Inc.

5485 Paré Street Suite 100

H4P 1P7, Montréal

address Ibex Technologies(IBT)


This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. IBT Stock
  4. Company Ibex Technologies